Trial intelligence / Profile preview

Methylnaltrexone vs Erythromycin for Gastric Emptying in ICU

NCT01117376Phase 2Terminated

Sponsor
Shiraz University of Medical Sciences
Start
May 2010
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methylnaltrexone in gastroparesis, sponsored by Shiraz University of Medical Sciences. Started May 2010; status: terminated.

02

Drugs

methylnaltrexone
03

Conditions

gastroparesis

Beyond the preview

Go deeper on NCT01117376.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01117376.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call